69 related articles for article (PubMed ID: 7431726)
21. The role of glucan in the prevention and modification of microparasitic diseases.
Di Luzio NR; Williams DL
Prog Clin Biol Res; 1984; 161():443-56. PubMed ID: 6435131
[No Abstract] [Full Text] [Related]
22. Modulation of liver fibrosis and pathophysiological changes in mice infected with Mesocestoides corti (M. vogae) after administration of glucan and liposomized glucan in combination with vitamin C.
Ditteová G; Velebný S; Hrckova G
J Helminthol; 2003 Sep; 77(3):219-26. PubMed ID: 12895280
[TBL] [Abstract][Full Text] [Related]
23. Hyporesponsiveness of murine myeloid progenitor cells to glucan following its repeated administration.
Pospísil M; Vacek A; Hofer M; Viklická S; Pipalová I; Sandula J
Folia Biol (Praha); 1993; 39(4):178-87. PubMed ID: 8187896
[TBL] [Abstract][Full Text] [Related]
24. Effect of macrophage stimulation on collagen biosynthesis in the healing wound.
Portera CA; Love EJ; Memore L; Zhang L; Müller A; Browder W; Williams DL
Am Surg; 1997 Feb; 63(2):125-31. PubMed ID: 9012425
[TBL] [Abstract][Full Text] [Related]
25. Inhibiting early activation of tissue nuclear factor-kappa B and nuclear factor interleukin 6 with (1-->3)-beta-D-glucan increases long-term survival in polymicrobial sepsis.
Williams DL; Ha T; Li C; Kalbfleisch JH; Laffan JJ; Ferguson DA
Surgery; 1999 Jul; 126(1):54-65. PubMed ID: 10418593
[TBL] [Abstract][Full Text] [Related]
26. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
Cheung NK; Modak S
Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
[TBL] [Abstract][Full Text] [Related]
27. Beta glucan vs bacterial infections - continuous daily use of yeast-derived beta glucan is questioned.
Posit Health News; 1998; (No 17):22-3. PubMed ID: 11366551
[TBL] [Abstract][Full Text] [Related]
28. [Study of immunobiological properties of specific immunomodulators of the adjuvant type in experimental tuberculosis].
Gorelova LA; Zemskova ZS; Panasek IA; Nekrasov AV; Puchkova NG; Moroz AM; Romanova RIu
Probl Tuberk; 1996; (3):46-7. PubMed ID: 8754882
[TBL] [Abstract][Full Text] [Related]
29. [Prospects in the search for new biological agents to prevent tuberculosis].
Kolomiets VM; Evglevskiĭ AA; Kovalenko AM; Timkova EA
Probl Tuberk; 2002; (10):31-3. PubMed ID: 12593166
[TBL] [Abstract][Full Text] [Related]
30. Effects after inhalation of (1-->3)-beta-D-glucan in healthy humans.
Thorn J; Beijer L; Rylander R
Mediators Inflamm; 2001 Aug; 10(4):173-8. PubMed ID: 11577993
[TBL] [Abstract][Full Text] [Related]
31. Soluble beta-1,3/1,6-glucan from yeast inhibits experimental periodontal disease in Wistar rats.
Breivik T; Opstad PK; Engstad R; Gundersen G; Gjermo P; Preus H
J Clin Periodontol; 2005 Apr; 32(4):347-52. PubMed ID: 15811050
[TBL] [Abstract][Full Text] [Related]
32. Effect of glucan immunomodulator on the immune response and larval burdens in mice with experimental toxocarosis.
Soltys J; Borosková Z; Dubinský P; Tomasovicová O; Auer H; Aspöck H
Appl Parasitol; 1996 Sep; 37(3):161-7. PubMed ID: 8856944
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulation by dietary beta-1, 3-glucan in the brooders of the black tiger shrimp Penaeus monodon.
Chang CF; Chen HY; Su MS; Liao IC
Fish Shellfish Immunol; 2000 Aug; 10(6):505-14. PubMed ID: 11016585
[TBL] [Abstract][Full Text] [Related]
34. Biological therapy of sepsis.
Norton JA
Ann Surg; 1994 Nov; 220(5):599-600. PubMed ID: 7979606
[No Abstract] [Full Text] [Related]
35. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
36. The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis.
Azevedo Cde M; Marques SG; Resende MA; Gonçalves AG; Santos DV; da Silva RR; de Sousa Mda G; de Almeida SR
Mycoses; 2008 Jul; 51(4):341-4. PubMed ID: 18444974
[TBL] [Abstract][Full Text] [Related]
37. [Carcinoma of the breast. Immune behaviour. Immunostimulation by fraction P40 (author's transl)].
Reynier J; Bazin JC; Bizzini B; Gandrille C; Guettier C; Henocq E; Hollmann K; Mogenet M; Pompidou A; Santus JP; Verley JM; Villet R
Chirurgie; 1980 Jan; 106(1):48-55. PubMed ID: 7379633
[No Abstract] [Full Text] [Related]
38. Evaluation of follow-up of therapy with fenbendazole incorporated into stabilized liposomes and immunomodulator glucan in mice infected with Toxocara canis larvae.
Hrckova G; Velebný S; Obwaller A; Auer H; Kogan G
Acta Trop; 2007; 104(2-3):122-32. PubMed ID: 17915186
[TBL] [Abstract][Full Text] [Related]
39. Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse rates.
Lenaerts AJ; Chapman PL; Orme IM
Tuberculosis (Edinb); 2004; 84(6):361-4. PubMed ID: 15525559
[TBL] [Abstract][Full Text] [Related]
40. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
